These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

624 related articles for article (PubMed ID: 18651252)

  • 1. Prevalence of acute reactions to iopromide: postmarketing surveillance study of 74,717 patients.
    Kopp AF; Mortele KJ; Cho YD; Palkowitsch P; Bettmann MA; Claussen CD
    Acta Radiol; 2008 Oct; 49(8):902-11. PubMed ID: 18651252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous contrast media in uroradiology: evaluation of safety and tolerability in almost 50,000 patients.
    Wendt-Nordahl G; Rotert H; Trojan L; Michel MS; Peters CR; Alken P; Knoll T
    Med Princ Pract; 2006; 15(5):358-61. PubMed ID: 16888393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and tolerability of iopromide intravascular use: a pooled analysis of three non-interventional studies in 132,012 patients.
    Palkowitsch PK; Bostelmann S; Lengsfeld P
    Acta Radiol; 2014 Jul; 55(6):707-14. PubMed ID: 24043880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute and late adverse reactions to low-osmolal contrast media.
    Mikkonen R; Kontkanen T; Kivisaari L
    Acta Radiol; 1995 Jan; 36(1):72-6. PubMed ID: 7833173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Late reactions to a radiologic contrast media (Iopamidol-Bracco). Prospective study].
    Bartolucci F; Cecarini M; Gabrielli G; Abbiati R; Barberio M; Busilacchi P
    Radiol Med; 2000 Oct; 100(4):273-8. PubMed ID: 11155455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and tolerability of iopromide in patients undergoing cardiac catheterization: real-world multicenter experience with 17,513 patients from the TRUST trial.
    Chen JY; Liu Y; Zhou YL; Tan N; Zhang B; Chen PY; Chen LB
    Int J Cardiovasc Imaging; 2015 Oct; 31(7):1281-91. PubMed ID: 26058857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and diagnostic image quality of iopromide: results of a large non-interventional observational study of European and Asian patients (IMAGE).
    Palkowitsch P; Lengsfeld P; Stauch K; Heinsohn C; Kwon ST; Zhang SX; Liang CH
    Acta Radiol; 2012 Mar; 53(2):179-86. PubMed ID: 22184683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Non-ionic iodinated dimeric versus monomeric X-ray contrast media: effects on complement factors in vivo].
    Böhm I; Speck U; Schild H
    Rofo; 2006 Mar; 178(3):306-12. PubMed ID: 16508838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Severe reactions to iodinated contrast agents: is anaphylaxis responsible?].
    Dewachter P; Mouton-Faivre C
    J Radiol; 2001 Sep; 82(9 Pt 1):973-7. PubMed ID: 11591924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and severity of acute allergic-like reactions to i.v. nonionic iodinated contrast material in children.
    Dillman JR; Strouse PJ; Ellis JH; Cohan RH; Jan SC
    AJR Am J Roentgenol; 2007 Jun; 188(6):1643-7. PubMed ID: 17515388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A possible role for cysteinyl-leukotrienes in non-ionic contrast media induced adverse reactions.
    Böhm I; Speck U; Schild H
    Eur J Radiol; 2005 Sep; 55(3):431-6. PubMed ID: 16129253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and patient comfort with iodixanol: a postmarketing surveillance study in 9515 patients undergoing diagnostic CT examinations.
    Häussler MD
    Acta Radiol; 2010 Oct; 51(8):924-33. PubMed ID: 20828300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed adverse reactions to iodinated contrast media and their risk factors.
    Hosoya T; Yamaguchi K; Akutsu T; Mitsuhashi Y; Kondo S; Sugai Y; Adachi M
    Radiat Med; 2000; 18(1):39-45. PubMed ID: 10852654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast media and nephropathy: findings from systematic analysis and Food and Drug Administration reports of adverse effects.
    Solomon R; Dumouchel W
    Invest Radiol; 2006 Aug; 41(8):651-60. PubMed ID: 16829749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adverse effects of contrast media: results of a 6 months study].
    Pelagatti V; Bagheri H; Fernandez P; Railhac N; Bregeon C; Railhac JJ; Montastruc JL
    Therapie; 2000; 55(3):391-4. PubMed ID: 10967718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Universal use of nonionic iodinated contrast medium for CT: evaluation of safety in a large urban teaching hospital.
    Mortelé KJ; Oliva MR; Ondategui S; Ros PR; Silverman SG
    AJR Am J Roentgenol; 2005 Jan; 184(1):31-4. PubMed ID: 15615946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention of severe reactions after iodinated contrast media injection: review of the literature].
    Dewachter P; Mouton-Faivre C
    J Radiol; 2003 May; 84(5):535-44. PubMed ID: 13677822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and tolerability of iobitridol in general and in patients with risk factors: results in more than 160,000 patients.
    Maurer M; Heine O; Wolf M; Freyhardt P; Schnapauff D; Hamm B
    Eur J Radiol; 2011 Nov; 80(2):357-62. PubMed ID: 20395094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of utilization and pharmacovigilance based on spontaneous adverse event reporting of gadopentetate dimeglumine as a magnetic resonance contrast agent after 45 million administrations and 15 years of clinical use.
    Knopp MV; Balzer T; Esser M; Kashanian FK; Paul P; Niendorf HP
    Invest Radiol; 2006 Jun; 41(6):491-9. PubMed ID: 16763467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug allergy in a population of surgical patients].
    Escolano F; Bisbe E; Castillo J; López R; Parés N; Arilla M; Castaño J
    Rev Esp Anestesiol Reanim; 1998 Dec; 45(10):425-30. PubMed ID: 9927834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.